Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Oncologist

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1634/theoncologist.2015-0416PMID 27286788PMCID PMC4943386
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico

  2015cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru

  2015cited by this paper
• Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population

  2014cited by this paper
• BRCA1 and BRCA2 – update and implications on the genetics of breast cancer: a clinical perspective

  2014cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia

  2014cited by this paper
• Triple-negative breast cancer and the need for new therapeutic targets.

  2013cited by this paper
• In Brief: BRCA1 and BRCA2

  2013cited by this paper
• Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

  2013cited by this paper
• Prevalence and impact of founder mutations in hereditary breast cancer in Latin America

  2013cited by this paper
• BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela.

  2012cited by this paper
• BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.

  2012cited by this paper
• Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer

  2012cited by this paper
• BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica

  2012cited by this paper
• Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers

  2012cited by this paper
• BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin

  2012cited by this paper
• Clinical significance of large rearrangements in BRCA1 and BRCA2

  2012cited by this paper
• BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants

  2011cited by this paper
• Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

  2010cited by this paper
• European Ancestry Is Positively Associated with Breast Cancer Risk in Mexican Women

  2010cited by this paper
• A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas

  2010cited by this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cited by this paper
• Genome-wide patterns of population structure and admixture among Hispanic/Latino populations

  2010cited by this paper
• BRCA mutations in the management of breast cancer: the state of the art

  2010cited by this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cited by this paper
• Genomic rearrangements in BRCA1 and BRCA2: A literature review

  2009cited by this paper
• Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.

  2009cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.

  2009cited by this paper
• BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

  2009cited by this paper
• Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome.

  2008cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba

  2008cited by this paper
• Geographic Patterns of Genome Admixture in Latin American Mestizos

  2008cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil

  2007cited by this paper
• High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia

  2007cited by this paper
• Founder mutations in BRCA1 and BRCA2 genes.

  2007cited by this paper
• Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.

  2007cited by this paper
• Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review

  2007cited by this paper
• Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

  2007cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

  2006cited by this paper
• BRCA1 and BRCA2 mutations in a South American population.

  2006cited by this paper
• Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations

  2005cited by this paper
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect

  2004cited by this paper
• Founder mutations among the Dutch

  2004cited by this paper
• The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

  2003cited by this paper
• Founder mutation in the BRCA1 gene in Malay breast cancer patients from Singapore

  2003cited by this paper
• Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status

  2003cited by this paper
• Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population

  2002cited by this paper
• A Founder Mutation of the BRCA1-Gene in Western Sweden

  2002cited by this paper
• BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines

  2002cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families

  2001cited by this paper
• A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

  2001cited by this paper
• Admixture studies in Latin America: from the 20th to the 21st century.

  2000cited by this paper
• Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

  2000cited by this paper
• Frequency of BRCA1 mutation 5382insC in German breast cancer patients.

  1999cited by this paper
• Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

  1999cited by this paper
• Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

  1996cited by this paper
• BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.

  1996cited by this paper

• Identifying a Recurrent BRCA1 Variant in the Qatari Population With Unique Genotype—Phenotype Correlations

  2026cites this paper
• Challenging the extended phenotype: HRD-negative salivary gland carcinoma in a BRCA1 founder-variant carrier, case report and literature review

  2026cites this paper
• Founder Variants in the Mexican Population: A Systematic Review.

  2025cites this paper
• Building a hereditary cancer program in Colombia: analysis of germline pathogenic and likely pathogenic variants spectrum in a high-risk cohort

  2025cites this paper
• Pathogenic variants in BRCA1 and BRCA2 genes associated with female breast and ovarian cancer in the Mexican population

  2025cites this paper
• Genomic landscape of hereditary cancer syndromes in the largest cohort in Colombia: a retrospective study

  2025cites this paper
• Program of Genomic Reference and Biobank of the Argentinian Population: A National Initiative for Genomic Equity and Population-Based Research in Argentina

  2025cites this paper
• A Quantitative Approach in Identifying Natural Selection Signals on Biallelic Single Nucleotide Polymorphisms of BRCA1 Gene in Diverse Populations

  2024cites this paper
• Variants in BRCA1/2 in a hospital-based cohort in Chile and national literature review

  2024cites this paper
• A Molecular Characterization of the Allelic Expression of the BRCA1 Founder Δ9–12 Pathogenic Variant and Its Potential Clinical Relevance in Hereditary Cancer

  2024cites this paper
• Detection of genomic variants in BRCA1 and BRCA2 across gastric cancer patients using next generation sequencing.

  2024cites this paper
• Molecular analysis of BRCA1 and BRCA2 genes in La Rioja (Spain): five new variants

  2024cites this paper
• Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.

  2024cites this paper
• Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System

  2024cites this paper
• Ovarian Cancer Isn't Just a White Woman's Disease.

  2024cites this paper
• Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru

  2023cites this paper
• La lucha contra el cáncer de mama: una revisión sistemática sobre la prevalencia del BRCA en Colombia

  2023cites this paper
• Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer

  2023cites this paper
• Real-world data on triple-negative breast cancer in Latin America and the Caribbean

  2023cites this paper
• Oncologic anthropology: Global variations in breast cancer risk, biology, and outcome

  2023cites this paper
• Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area

  2023cites this paper
• Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis

  2022cites this paper
• Características clínicas de pacientes con Cáncer de Mama y / o Cáncer de Ovario con mutaciones en los genes BRCA1 y BRCA2 en Córdoba, Argentina

  2022cites this paper
• Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients

  2022cites this paper
• The GALNS p.P77R variant is a probable Gujarati-Indian founder mutation causing Mucopolysaccharidosis IVA syndrome

  2022cites this paper
• Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12

  2022cites this paper
• BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients

  2022cites this paper
• Systemic sclerosis manifestations and clinical outcomes in Hispanics/Latinos of the American Southwest

  2022cites this paper
• Founder variants and population genomes-Toward precision medicine.

  2021cites this paper
• Double heterozygous pathogenic variants in the BRCA1 and BRCA2 genes in a patient with bilateral metachronous breast cancer.

  2021cites this paper
• Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants

  2021cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• Mutations in BRCA-related breast and ovarian cancer in the South African Indian population: A descriptive study.

  2021cites this paper
• Discovery of BRCA1/BRCA2 founder variants by haplotype analysis.

  2021cites this paper
• Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer

  2020cites this paper
• Clinicopathological Features of Patients with the BRCA1 c.5339T>C (p.Leu1780Pro) Variant

  2020cites this paper
• BRCA and PALB2 mutations in a cohort of male breast cancer with one bilateral case.

  2020cites this paper
• Analysis of Heterozygous BRCA1 5382ins Founder Mutation in a Cohort of Egyptian Breast Cancer Female Patients Using Pyrosequencing Technique

  2020cites this paper
• Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care

  2020cites this paper
• Cáncer de mama en seis familias del Tolima y el Huila: mutación BRCA1 3450del4

  2020cites this paper
• Genetics and Genomics of Breast Cancer: update and translational perspectives.

  2020cites this paper
• Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers

  2020cites this paper
• Investigation into the origins of an ancient BRCA1 founder mutation identified among Chinese families in Singapore

  2020cites this paper
• Identification of Important Modules and Biomarkers in Breast Cancer Based on WGCNA

  2020cites this paper
• Five Italian Families with Two Mutations in BRCA Genes

  2020cites this paper
• Identi fi cation of Important Modules and Biomarkers in Breast Cancer Based on WGCNA

  2020influential citation
• THE HUMAN VARIOME PROJECT COUNTRY NODE OF ARGENTINA IN THE FIRST TWO YEARS OF ACTIVITY: PAST, PRESENT AND FUTURE

  2019cites this paper
• Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach

  2019cites this paper
• Algorithm of molecular genetic investigation to identify hereditary BRCA-associated breast cancer

  2019cites this paper
• Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

  2019cites this paper
• Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy

  2019cites this paper
• Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients

  2019cites this paper
• Novel bioinformatics quality control metric for next-generation sequencing experiments in the clinical context

  2019cites this paper
• Breast Cancer with Hereditary Cancer Predisposition Syndromes

  2019cites this paper
• Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study

  2019cites this paper
• Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer

  2019cites this paper
• Novel BRCA2 pathogenic variant c.5219 T > G; p.(Leu1740Ter) in a consanguineous Senegalese family with hereditary breast cancer

  2019cites this paper
• Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation

  2019cites this paper
• Алгоритм молекулярно-генетического обследования для выявления наследственного BRCA -ассоциированного рака молочной железы

  2019cites this paper
• Breast Cancer Prevention

  2019cites this paper
• Genetic Epidemiology of Breast Cancer in Latin America

  2019cites this paper
• Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

  2019influential citation
• A scalable, aggregated genotypic–phenotypic database for human disease variation

  2019cites this paper
• Population and breast cancer patients’ analysis reveals the diversity of genomic variation of the BRCA genes in the Mexican population

  2019cites this paper
• Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil

  2019cites this paper
• Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era

  2018cites this paper
• Estimating the age of the p.Cys433Arg variant in the MYOC gene in patients with primary open-angle glaucoma

  2018cites this paper
• Genetics of breast cancer in African populations: a literature review

  2018influential citation
• Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.

  2018cites this paper
• Capillary electrophoresis as alternative method to detect tumor genetic mutations: the model built on the founder BRCA1 c.4964_4982del19 variant

  2018cites this paper
• BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

  2018cites this paper
• The germline mutational landscape of BRCA1 and BRCA2 in Brazil

  2018cites this paper
• Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

  2018cites this paper
• BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile

  2017cites this paper
• High Resolution Melting Analysis is Very Useful to Identify Breast Cancer Type 1 Susceptibility Protein (BRCA1) c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA

  2017cites this paper
• A multi-gene panel study in hereditary breast and ovarian cancer in Colombia

  2017cites this paper
• Cancer Genomic Resources and Present Needs in the Latin American Region

  2017cites this paper
• CÓMO ORGANIZAR Y ESTRUCTURAR UN PROGRAMA DE SÍNDROMES HEREDITARIOS QUE PREDISPONEN AL DESARROLLO DEL CÁNCER

  2017cites this paper
• Mutational spectrum in breast cancer associated BRCA1 and BRCA2 genes in Colombia

  2017cites this paper
• Variation in type II endometrial cancer risk by Hispanic subpopulation: An exploratory analysis.

  2017cites this paper
• Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil

  2016cites this paper